171 related articles for article (PubMed ID: 22539608)
1. Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.
Ahearn TU; Shaukat A; Flanders WD; Seabrook ME; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):969-79. PubMed ID: 22539608
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients.
Ahearn TU; Shaukat A; Flanders WD; Rutherford RE; Bostick RM
Cancer Prev Res (Phila); 2012 Oct; 5(10):1247-56. PubMed ID: 22964475
[TBL] [Abstract][Full Text] [Related]
3. Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients.
Liu S; Barry EL; Baron JA; Rutherford RE; Seabrook ME; Bostick RM
Mol Carcinog; 2017 Feb; 56(2):412-424. PubMed ID: 27254743
[TBL] [Abstract][Full Text] [Related]
4. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
7. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, beta-catenin and APC protein in canine colorectal tumours.
Restucci B; Martano M; DE Vico G; Lo Muzio L; Maiolino P
Anticancer Res; 2009 Aug; 29(8):2919-25. PubMed ID: 19661296
[TBL] [Abstract][Full Text] [Related]
9. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms.
Tu H; Ahearn TU; Daniel CR; Gonzalez-Feliciano AG; Seabrook ME; Bostick RM
Mol Carcinog; 2015 Sep; 54(9):821-30. PubMed ID: 24719252
[TBL] [Abstract][Full Text] [Related]
13. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Cohen VL; Dash C; Seabrook ME; Fedirko V
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1599-609. PubMed ID: 19423536
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
16. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.
Prall F; Weirich V; Ostwald C
Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Kohler EM; Brauburger K; Behrens J; Schneikert J
Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
